Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer

Veterinary and Comparative Oncology

Volumn 8, Issue 4, 2010, Pages 293-301

  Klopfleisch, R ^a   Hvid, H ^b   Klose, P ^a   Da Costa, A ^a   Gruber, A D ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast cancer; Canine; Dog; Insulin receptor; Insulin like growth factor; Insulin like growth factor receptor; Mammary tumour; Metastasis

Indexed keywords

INSULIN RECEPTOR; MESSENGER RNA;

ADENOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; BREAST TUMOR; CARCINOMA; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE; METABOLISM; MULTIGENE FAMILY; PATHOLOGY; POLYMERASE CHAIN REACTION; UDDER;

ADENOMA; ANIMALS; BREAST NEOPLASMS; CARCINOMA; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; RECEPTOR, INSULIN; RNA, MESSENGER;

CANIS FAMILIARIS;

EID: 78349231987     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2009.00232.x     Document Type: Article

References (32)

1. Pollak M. Targeting insulin and insulin-like growth factor signalling in oncology. Current Opinion in Pharmacology 2008; 8: 384-392.
2. Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annual Review of Biochemistry 1992; 61: 307-330.
3. Oka Y, Rozek LM and Czech MP. Direct demonstration of rapid insulin-like growth factor II receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. The Journal of Biological Chemistry 1985; 260: 9435-9442.
4. Soos MA, Whittaker J, Lammers R, Ullrich A and Siddle K. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. The Biochemical Journal 1990; 270: 383-390.
5. Ward CW and Lawrence MC. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioessays 2009; 31: 422-434.
6. Nakae J, Kido Y and Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocrine Reviews 2001; 22: 818-835.
7. Stewart CE and Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiological Reviews 1996; 76: 1005-1026.
8. Bartke A. Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 2005; 146: 3718-3723.
9. Holly JM and Perks CM. Cancer as an endocrine problem. Best Practice & Research. Clinical Endocrinology & Metabolism 2008; 22: 539-550.
10. Smith U and Gale EA. Does diabetes therapy influence the risk of cancer? Diabetologia 2009; 52: 1699-1708.
11. Ehninger G and Schmidt AH. Putting insulin glargine and malignancies into perspective. Oncologist 2009; 14: 1169-1174.
12. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID and Vigneri R. Elevated insulin receptor content in human breast cancer. The Journal of Clinical Investigation 1990; 86: 1503-1510.
13. Vigneri P, Frasca F, Sciacca L, Pandini G and Vigneri R. Diabetes and cancer. Endocrine-Related Cancer 2009; 16: 1103-1123.
14. Mulligan AM, O'Malley FP, Ennis M, Fantus IG and Goodwin PJ. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Research and Treatment 2007; 106: 39-47.
15. Heuson JC, Legros N and Heimann R. Influence of insulin administration on growth of the 7, 12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats. Cancer Research 1972; 32: 233-238.
16. Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A and Vigneri R. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Archives of Physiology and Biochemistry 2008; 114: 23-37.
17. Belfiore A and Frasca F. IGF and insulin receptor signaling in breast cancer. Journal of Mammary Gland Biology and Neoplasia 2008; 13: 381-406.
18. Queiroga FL, Perez-Alenza MD, Silvan G, Pena L, Lopes CS and Illera JC. Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours. The Journal of Steroid Biochemistry and Molecular Biology 2008; 110: 76-82.
19. Mol JA, Selman PJ, Sprang EP, Van Neck JW and Oosterlaken-Dijksterhuis MA. The role of progestins, insulin-like growth factor (IGF) and IGF-binding proteins in the normal and neoplastic mammary gland of the bitch: a review. Journal of Reproduction and Fertilility Supplement 1997; 51: 339-344.
20. Papa V, Gliozzo B, Clark GM, McGuire WL, Moore D, Fujita-Yamaguchi Y, Vigneri R, Goldfine ID and Pezzino V. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Research 1993; 53: 3736-3740.
21. Resnik JL, Reichart DB, Huey K, Webster NJ and Seely BL. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Research 1998; 58: 1159-1164.
22. Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK, Camuso AE, Gottardis M, Greer AF, Ho CP, Hurlburt W, Li A, Saulnier M, Velaparthi U, Wang C, Wen ML, Westhouse RA, Wittman M, Zimmermann K, Rupnow BA and Wong TW. Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Research 2005; 65: 3781-3787.
23. Misdorp W, Else RW, Hellmén E and Lipscomb TP. Histological Classification of Mammary Tumors of the Dog and the Cat. Washington, Armed Forces Institute of Pathology, 1999.
24. Klopfleisch R and Gruber AD. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas. Journal of Comparative Pathology 2009; 141: 113-120.
25. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
26. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002; 3: 34.1-34.11.
27. Etschmann B, Wilcken B, Stoevesand K, Von Der Schulenburg A and Sterner-Kock A. Selection of reference genes for quantitative real-time PCR analysis in canine mammary tumors using the GeNorm algorithm. Veterinary Pathology 2006; 43: 934-942.
28. Bieche I, Nogues C and Lidereau R. Overexpression of BRCA2 gene in sporadic breast tumours. Oncogene 1999; 18: 5232-5238.
29. Khandwala HM, McCutcheon IE, Flyvbjerg A and Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocrine Reviews 2000; 21: 215-244.
30. Sachdev D and Yee D. The IGF system and breast cancer. Endocrine-Related Cancer 2001; 8: 197-209.
31. Van Garderen E, Van Der Poel HJ, Swennenhuis JF, Wissink EH, Rutteman GR, Hellmen E, Mol JA and Schalken JA. Expression and molecular characterization of the growth hormone receptor in canine mammary tissue and mammary tumors. Endocrinology 1999; 140: 5907-5914.
32. Berthe ML, Esslimani Sahla M, Roger P, Gleizes M, Lemamy GJ, Brouillet JP and Rochefort H. Mannose-6- phosphate/insulin-like growth factor-II receptor expression levels during the progression from normal human mammary tissue to invasive breast carcinomas. European Journal of Cancer 2003; 39: 635-642.